930TiPPhase II/III study of rogaratinib versus chemotherapy in patients with locally advanced or metastatic urothelial carcinoma selected based on FGFR1/3 mRNA expression. (23rd October 2018) - Sternberg, C N; Bellmunt, J; Nishiyama, H; Petrylak, D P; Quinn, D I; Nakajima, K; Lu, C; Holynskyj, A